| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.86B | -1.5% |
| Cost of Revenue | $1.65B | +7.8% |
| Gross Profit | $213.0M | -40.7% |
| R&D Expense | $16.0M | +14.3% |
| SG&A Expense | $245.2M | +8.7% |
| Operating Income | -$36.5M | -129.7% |
| Pre-tax Income | -$97.4M | -165.1% |
| Income Tax | $13.5M | -78.7% |
| Net Income | -$110.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.2M | -68.9% |
| Accounts Receivable | $284.4M | -2.3% |
| Inventory | $628.6M | -4.3% |
| Current Assets | $994.5M | -10.0% |
| Total Assets | $1.82B | -5.1% |
| Current Liabilities | $368.8M | -22.6% |
| Long-term Debt | $557.4M | +9.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.5M | -96.6% |
| Capital Expenditures | $42.9M | +45.4% |
| Investing Cash Flow | -$42.9M | +77.0% |
| Financing Cash Flow | -$36.3M | -237.0% |
| Free Cash Flow | -$40.4M | -194.0% |
| -228.7% |
| EPS (Basic) | -$0.96 | -228.0% |
| EPS (Diluted) | -$0.96 | -228.0% |
| Stockholders' Equity |
| $751.1M |
| -8.1% |